Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Advances in Therapy|May 14, 2020
Consensus Recommendations for Management and Counseling of Adverse Events Associated With Lorlatinib: A Guide for Healthcare PractitionersMollie Reed, Aimee-Lauren S Rosales, Marc D Chioda, et al.
The Oncologist|March 21, 2019
Clinical Management of Adverse Events Associated with LorlatinibTodd M Bauer, Enriqueta Felip, Benjamin J Solomon, et al.
Drugs - Real World Outcomes|July 30, 2020
Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung CancerDavid M Waterhouse, Janet L Espirito, Marc D Chioda, et al.
The Oncologist|September 3, 2015
Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based RecommendationsBenjamin P Levy, Marc D Chioda, Dana Herndon, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic PainHarry R Chobanian, Yan Guo, Ping Liu, et al.
Pageof 1